1.38Open1.55Pre Close337 Volume277 Open Interest107.00Strike Price38.22KTurnover53.63%IV0.42%PremiumDec 13, 2024Expiry Date1.26Intrinsic Value100Multiplier0DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type-0.8495Delta0.1976Gamma76.91Leverage Ratio-0.8567Theta-0.0004Rho-65.33Eff Leverage0.0052Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet